Hypertension typically isn’t going to create clinical results up to the point vascular changes in the heart, brain, or kidneys come about. Greatly elevated blood pressure can cause damage to the intima of small vessels, resulting in fibrin accumulation in the vessels, creation of local edema and, quite possibly, intravascular clotting.
Symptoms produced through this procedure depend on the location of the damaged vessels:
Brain: cerebrovascular accident (CVA)
Retina: blindness
Heart: myocardial infarction (MI)
Kidneys: proteinuria, edema and, eventually, renal failure.
Hypertension increases the heart’s workload, producing left ventricular hypertrophy and, later, left ventricular failure, left- and right-sided heart failure, and pulmonary edema.
An increase of the systolic and/or diastolic blood pressure increases the chance of getting heart illness, kidney disease, atherosclerosis or arteriosclerosis, eye problems, and brain damage. Such difficulties of hypertension are frequently referred to as end-organ damage simply because damage to the organs is an end result of chronic high blood pressure. For that reason, the diagnosis of high blood pressure is essential so efforts can be created to normalize blood pressure and prevent complications.
Heart failure engagement in hypertension sometimes shows as left ventricular hypertrophy (LVH), left atrial enlargement, aortic root dilatation, atrial and ventricular arrhythmias, systolic and diastolic heart failure, and ischemic heart disease. LVH is associated with an elevated chance of early death and morbidity. A higher frequency of cardiac atrial and ventricular dysrhythmias and sudden cardiac death may exist. Possibly, elevated coronary arteriolar resistance leads to decreased blood flow towards the hypertrophied myocardium, resulting in angina despite clean coronary arteries. Hypertension, along with decreased oxygen supply and other chance factors, accelerates the procedure of atherogenesis, in that way further reducing oxygen delivery towards the myocardium.
The myocardium undergoes structural changes in response to elevated after load. Cardiac myocytes respond by hypertrophy, allowing the heart to pump more strongly against the elevated pressure. However, the contractile function of the left ventricle remains normal until later stages. Eventually, LVH lessens the chamber lumen, limiting diastolic filling and stroke volume. The left ventricular diastolic function is markedly compromised in long-standing hypertension.
Long-standing hypertension may manifest as hemorrhagic and atheroembolic stroke or encephalopathy. Both the high systolic and diastolic pressures are harmful; a diastolic pressure of more than 100 mmHg and a systolic pressure of more than 160 mmHg have led to a significant incidence of strokes. Other cerebrovascular manifestations of complex hypertension consist of hypertensive haemorrhage, hypertensive encephalopathy, lacunar-type infarctions, and dementia.
Nephrosclerosis is one of the possible difficulties of long-standing hypertension. The chance of hypertension-induced end-stage kidney disease is higher in black individuals, even if the blood pressure is under good control. Furthermore, individuals with diabetic nephropathy who are hypertensive are likewise at high chance for getting end-stage kidney disease. The renin-angiotensin system activity influences the progression of kidney disease. Angiotensin II acts at both the afferent and also the efferent arterioles, but more so on the efferent arteriole, which leads to an increase of the intraglomerular pressure. The excess glomerular pressure leads to microalbuminuria. Decreasing intraglomerular pressure using an ACE inhibitor has been shown to be beneficial in individuals with diabetic nephropathy, even in those who aren’t hypertensive. The beneficial effect of ACE inhibitors on the progression of renal insufficiency in patients who are non-diabetic is less clear.
